Academic Background
I studied medicine at Brasenose College and Green Templeton College, Oxford graduating in 2021. I achieved an MBA whilst sitting my medical school finals. I have continued my postgraduate training in Oxford as an Academic Foundation Doctor and subsequently an NIHR Academic Clinical Fellow in Haematology. I am studying a part-time Masters in Genomic Medicine at Fitzwilliam College, Cambridge alongside my current clinical role. I gained an Associate Fellowship of the Higher Education Academy in 2023. I was awarded the Kathleen Lavidge Bursary to study pandemic viruses at Stanford University in 2016.
Undergraduates Teaching Areas
I teach clinical medical students at Jesus College.
Research Interests
My research interests have been varied, comprising a human challenge model of Typhoid fever, the development of the Oxford-AstraZeneca COVID-19 vaccine, several systematic reviews and meta-analyses, and genetic ethics. During my Academic Clinical Fellowship, I am working with Dr Sarah Gooding to use multi-omic approaches to understand molecular drivers and therapeutic targets in Multiple Myeloma, a type of blood cancer originating in the cells that make antibodies.
Other Information
I am a qualified trampolining gymnastics coach and can do a double-back somersault!
Publications
2022.
- From proband to provider: is there an obligation to inform genetic relatives of actionable risks discovered through direct-to-consumer genetic testing?
JA Parsons, PE Baker
Journal of Medical Ethics 48 (3), 205-212 - Cánulas nasales de alto flujo para la asistencia respiratoria en pacientes adultos de cuidados intensivos
SR Lewis, PE Baker, R Parker, AF Smith
Emergencias: Revista de la Sociedad Española de Medicina de Urgencias y - An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females
NG Marchevsky, G Li, P Aley, SAC Clemens, JR Barrett, …
EBioMedicine 81
2021.
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, …
The Lancet 397 (10269), 99-111 - Tolerability and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 (AZD1222)
A Flaxman, N Marchevsky, D Jenkin, J Aboagye, P Aley, B Angus
Available at SSRN 3873839 - Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, …
The Lancet 397 (10277), 881-891 - Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
S Feng, DJ Phillips, T White, H Sayal, PK Aley, S Bibi, C Dold, M Fuskova, …
Nature medicine 27 (11), 2032-2040 - AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific TH1 response with a diverse TCR repertoire
PA Swanson, M Padilla, W Hoyland, K McGlinchey, PA Fields, S Bibi, …
Science translational medicine 13 (620), eabj7211 - Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B. 1.1. 7): an exploratory analysis of a randomised controlled trial
KRW Emary, T Golubchik, PK Aley, CV Ariani, B Angus, S Bibi, B Blane, …
The Lancet 397 (10282), 1351-1362 - T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trialKJ Ewer, JR Barrett, S Belij-Rammerstorfer, H Sharpe, R Makinson, …
Nature medicine 27 (2), 270-278 - Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
JR Barrett, S Belij-Rammerstorfer, C Dold, KJ Ewer, PM Folegatti, …
Nature medicine 27 (2), 279-288 - Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002)
A Flaxman, NG Marchevsky, D Jenkin, J Aboagye, PK Aley, B Angus, …
The Lancet 398 (10304), 981-990
2020.
- Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, …
The Lancet 396 (10249), 467-478 - Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, …
The Lancet 396 (10267), 1979-1993 - Interventions to reduce body temperature to 35 ⁰C to 37 ⁰C in adults and children with traumatic brain injury
SR Lewis, PE Baker, PJD Andrews, A Cheng, K Deol, N Hammond, …
Cochrane database of systematic reviews - Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model
MM Gibani, C Jin, S Shrestha, M Moore, L Norman, M Voysey, E Jones, …
PLOS Neglected Tropical Diseases 14 (10), e0008783
2019.
- Long‐term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis
EX Georgiou, P Melo, PE Baker, HN Sallam, A Arici, JA Garcia‐Velasco, …
Cochrane Database of Systematic Reviews - The Impact of Vaccination and Prior Exposure on Stool Shedding of Salmonella Typhi and Salmonella Paratyphi in 6 Controlled Human Infection Studies
MM Gibani, M Voysey, C Jin, C Jones, H Thomaides-Brears, E Jones, …
Clinical Infectious Diseases 68 (8), 1265-1273 - Long-term gonadotrophin-releasing hormone agonist (GnRHa) therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis: a Cochrane …
E Georgiou, P Melo, P Baker, HN Sallam, A Arici, JA Garcia-Velasco, …
Human Reproduction 34 (S1)
2017.
- High‐flow nasal cannulae for respiratory support in adult intensive care patients
SR Lewis, PE Baker, R Parker, AF Smith
Cochrane Database of Systematic Reviews